Member Info for DShox

Never mind

Anyway, user feedback might've helped the upgrade announced in August and the game has changed. Important to keep up to spot opportunity.

Yes agree. It's the first mention of BHA supplied Healgen being in test phase in public and we're also increasingly hearing of the need to improve the freedom and flexibility of people. What BHA has that no other has is the link to COV-ID.

BHA has UK exclusivity to the finger-prick test made by Antai. This might be more relevant than Healgen at home or at airports because it picks up asymptomatic cases.

But a digital passport to foster public compliance and a re-opening of life looks increasingly in demand.

Actually CTEAs technology can be used with anyone's tests, whether they are rapid or not, part of a corporate, government or even private home test. The JV just opens a greater number of doors particularly in Africa given BHA's clinical network and the fact it attracted Afrik-ID.

I saw someone bemoaning the slow progress with Afrik-ID. Think about it. CTEA and BHA were in talks from July and do you really think Afrik-ID were kept out the loop? Afrik-ID MoU was signed quite purposefully post JV formation. I suspect lots of useful feedback was given to improve the COV-ID and Onsite-ID apps as per August RNS.

Hopefully it's a good run to finish line. COVID has actually changed the supply dynamic for US Nat Gas.

Public Health England and NHS planning spend totalling £42bn, part of Operation Moonshot.

Effective IT and population management tools increasingly discussed as hitherto ineffective and key tool to re-opening public places and air traffic. CTEAs upgraded app gives government and corporates ability to spot and respond to break out hotspots, as COVID appears in clusters.

China is preparing to test 11m in Wuhan as a result of less than 30 people found positive with COVID.

Spike? The suspension is signalling a deal and therefore sustainable exit attached to a technical valuation. There's always peaks and troughs, but the window for that behaviour looks to be closing.

UK and SADC
Global ambition

I disagree. CTEA is EU GDPR compliant, BHA has UK exclusivity on Antai and has just seen Healgen passed in UK, with a UK subsidiary and supplied UK FTSE100s. Africa is additional growth.

The BHA team is also adding trained and training staff to capacity. When someone has a test, I expect a unique QR code will be scanned attached to a BHA supplied product. This allows COV-ID to be tested at the same time.

The 350k units supplied to FTSE100s might be the Antai (finger prick test) for which BHA has UK exclusivity for. That picks up asymptomatic cases too.

Widely reported incl BBC News at Ten that you need -80 deg C storage so that's a challenge across the less developed world.

Watched the Parliamentary Select Committee meeting. From 10:56 to 10:58:

- 6 out of 50 rapid tests passed Government muster led by Professor Bell (we know Healgen Antigen passed at Porton Down given Proactive interview and ref to Dept of Health England website showing it underwent Phase 3 w/c 28 Sept)
- Professor Bell very impressed by these LFT test results
- Lady that speaks after him talks about effective population monitoring with results backed by proper IT
- Before this segment, another discussion on effective IT and importance of spotting outbreaks in populations as COVID occurs in clusters

All exactly what CTEAs platform does per RNS.

COV-ID got upgraded in August.

Hopefully government announces the LFT tests to public today and that will clarify once and for all whether BHA is or has an opportunity to supply Healgen Antigen and therefore get the JV holistic on the table also.

I think Guy Meyer mean't or might better have said 'cliff face' rather than 'cliff edge' - folk that've tried touching the latter have usually met with an untimely demise ;)

COV-ID got an upgrade as announced in August and just waiting for the JV, and CTEA outside the JV, to announce new sales. As per Sunday's podcast, CTEAs directors include guys that developed and launched the iPlayer for BBC and the first digital map of the world.

I reckon the Boards of CTEA and BHA know their industries.

Bounce off supports seen last couple days and its volume backed.

The right RNS and this goes...

MMs did a co-ordinated raid. To me, no issue.

You'll have heard Guy Meyer in the Proactive 3.5 weeks ago say COVID is part of the new normal. I happen to think the same.

Many unknowns with the vaccine and in any case, you won't get life long or even more than a few months immunity in some cases.

Still the very clear and present need to get testing, track, trace and global monitoring in place.

The rise will come from an even lower share price, that's all.

Yes agree with below - I'm sure commercial sensitivities are in play here as Gov has not made a public order for Healgen and/or Antai.

Here's the right link - very confident this includes our newly Porton Down passed Healgen:

https://www-bbc-co-uk.cdn.ampproject.org/v/s/www.bbc.co.uk/news/amp/uk-54870145?amp_js_v=a6&_gsa=1&usqp=mq331AQFKAGwASA%3D#aoh=16049206916067&referrer=https%3A%2F%2Fwww.google.com&_tf=From%20%251%24s

Good PR.

If peeps look at the Dept of Health England website, Porton Down recently passed the first 3 Lateral Flow Tests - one is Innova's and one our JV's Healgen. These are the only two Lateral Flow Technology swab tests.

Although not clear from the Gov webpage, Innova looks to have passed Phase 3 tests either late Sept or week 1 of October. So say 1-2 weeks post pass, it scored a >£110m contract for Liverpool.

Given Healgen's Phase 3 test was recorded w/c 28 Sept, it passed mid-Oct.

Gov placed the Innova order quickly and without tender, as it can under emergency powers.

What's clear now is Innova's product doesn't work in asymptomatic population and is accurate only when ppl are showing symptoms in first 5 days.

How the Healgen Antigen swab tests performs vs Innova's will be interesting but having said that, our JV's Antai Triple Antibody Test (because it detects the three antibodies that fights the virus) picks up current and past symptomatic and asymptomatic persons - far more relevant than Innova's limited range and key to getting people back on flights. This Antai Technologies manufactured kit is exclusive to our JV and FTSE100 co's have already bought 350k units (before JV formed) and these two co's are now looking at CTEAs COV-ID app.

Operation Moonshot wants to tests 10m ppl per day by 2021 and an initial £12bn allocated. Grant Shapps recently said he wants airport testing in place by 01 Dec and see this being paid by travelers (family member paid £90).

No other company has a holistic, trusted, secure Blockchain backed COVID population monitoring and management platform linked to rapid testing capability and capacity as far as I know.

Both our JVs tests respond within 15-20mins and record the result on the Blockchain and results sent to your phone. Both Healgen and Antai are Chinese and have massive, cheap manufacturing capacity.

When CTEA and BHA call this the "solution to this massive global pandemic", "the solution of the future" and "the JV's growth within touching distance of a cliff edge", I see lots of green flashing lights.

Last and potentially highly explosive cheap COVID stock, which also applies to other areas of course and infectious diseases such as TB, HIV.

Haven't even mentioned the huge opportunity of Afrik-ID in SADC serving c.350m ppl.

Ste, PIs can be easily frustrated. News ideally must be kept value accretive or sufficiently material to accrete value.

Few months ago, Guy Meyer told us the difficult job of building the product and cutting excess cost is done. 3 weeks ago he told us its all about "securing contracts" and "sales, sales, sales", along with BHA's Gavyn Hough telling us BHA had fully focused efforts on COVID.

We also learned from that interview CTEA and BHA have been talking since July/Aug, and in that short time, BHA has supplied 350k test kits to 2 FTSE100 companies that are keen to test the holistic JV solution and that because "we have access to top company level, the opportunity is open and other companies will follow suit".

Both Guy and Gavyn agreed it is "the solution of the future".

Many of us are super confident that large deals are poised to be announced with corporates and governments and once they land, forget NT to buy at 3.8p or 4p, you'll see a multibag first powered by shorts desperately running for cover - these guys are more nervous of a contract landing than longs.

The fundraise rubbish is two a penny on LSE bbs. As Guy said, both businesses are hugely scalable and as contracts land, its straight to the bottom line against a very low cost base where the directors are taking payment largely in shares.

I'm not a decimal point man or a proxy 10% trader. Decent position sizes and wait. Can't buy volume so cheap when the RNSs land.

Yep

Right on point - couple sells drop in.

Wait for best price to add.

NT is there sometimes to protect idiots from themselves imv but alas, this retrace has stuttered and died a lowly death that could've been rescued with the integrated, scalable, GDPR compliant, hack proof, Blockchain backed, UK gov approved test, track and trace product from CTEA-Blackhive that now has Afrik-ID knocking.

Oil and gas - not my forte. Quick look at CBM Project on website has $37m already spent on wells, pipes and infrastructure and US Nat Gas price has perked up back to $3. Agree SSSIG has funded CZNs existence and probably don't need to extend "exclusivity" at this point. Sub £1m cap, worth a punt. Lockdowns appear to have delayed the show.